Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

VoiceMed-WomenTechEU

Financiado

MONITOR RESPIRATORY HEALTH USING VOICE

Voice can tell a lot of information about our health. We believe that voice is the new blood for medical diagnosis. Asthma is a long-term disease that affects the lungs and airways. It is one of the most common chronic diseases w... ver más

30/06/2024

VOICEMED SARL

75K€

Presupuesto del proyecto: 75K€

Líder del proyecto

VOICEMED SARL No se ha especificado una descripción o un objeto social para esta compañía.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-06-30

HORIZON-EIE-2022-SCALEUP-02-02: Women TechEU ExpectedOutcome:Project results are expected to contribute to the following expected outcomes:

Innovación

Cerrada hace 2 años

0% 100% 100%

1 Participantes

VOICEMED SARL

75.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

AI4LUNGS AI-BASED PERSONALISED CARE FOR RESPIRATORY DISEASE USING MUL... 7M€ Cerrado

PTQ2020-011141 BIOSENSAI - Detección de enfermedades respiratorias mediante... 24K€ Cerrado

FJC2021-046986-I Evaluation of Novel Imaging Technologies combined with Artif... 65K€ Cerrado

DIAGNOSTICO DE LA APENA DEL SUEÑO MEDIANTE AN... DIAGNOSTICO DE LA APENA DEL SUEÑO MEDIANTE ANÁLISIS DE VOZ (... 21K€ Cerrado

INVESTIGACIÓN Y DESARROLLO DE NUEVAS TECNOLOG... INVESTIGACIÓN Y DESARROLLO DE NUEVAS TECNOLOGÍAS ELECTROMÉDI... 445K€ Cerrado

Duración del proyecto: 12 meses Fecha Inicio: 2023-05-31
Fecha Fin: 2024-06-30

Líder del proyecto

VOICEMED SARL No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 75K€

Descripción del proyecto Voice can tell a lot of information about our health. We believe that voice is the new blood for medical diagnosis. Asthma is a long-term disease that affects the lungs and airways. It is one of the most common chronic diseases with 5.8% of the EU population suffering from asthma - ~30 mill people. Doctors have always relied on the patient’s voice as one of the first parameters to assess health. When they talk to a patient, they carefully listen to their breathing, cough, and speech looking for specific signs. However, doctors usually evaluate patients without using any digital solution, leading to a 50% rate in non-well-controlled patients. Deep-tech innovation: VoiceMed uses vocal biomarkers combined with sound analysis and artificial intelligence. Our technology detects subtle signals in the sounds produced by the vocal apparatus. When the association between a signal either a normal biological or pathogenic state is fully validated, these signals become vocal biomarkers. This process allows going beyond the sounds routinely used in medical practice, such as wheezes or crackles, and unlocking a new dimension of biomarkers that can be assessed remotely, instantaneously and with no extra equipment. Women Founders: Arianna Arienzo (CEO) - +6 years experience in business in 5 countries (including Silicon Valley). Entrepreneur in digital health and digital technologies. Listed in Forbes Under 30 in 2022. Contract professor at Cattolica university in healthcare innovation. Msc business administration. Dr. Ayana de Brito (CSO) - +9 years’ experience as a research scientist in computational biology, currently leading our research team. She has skills in scientific practices, scientific writing, pm, strategic planning, data analysis, statistics, data visualization and programming. She is an expert also in regulatory affairs, with knowledge also in privacy. PhD in computational biologist.

Conecta tu I+D

Entra hoy

¿Olvide mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores